NJ SR25 | 2020-2021 | Regular Session

Note: Carry Foward to future SR35
Note: Carry Foward to future AR90
Note: Carry Over of previous SR26
Note: Carry Over of previous AR116

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 30 2020 - 25% progression, died in committee
Action: 2020-01-30 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
Pending: Senate Health, Human Services and Senior Citizens Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Urges FDA to make naloxone available over the counter.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Urges FDA to make naloxone available over the counter.

Sponsors


History

DateChamberAction
2020-01-30SenateIntroduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee

Same As/Similar To

SR25 (Carry Over) 2020-01-30 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
SR25 (Carry Over) 2020-01-30 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
SR26 (Carry Over) 2018-01-16 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
AR116 (Carry Over) 2018-02-08 - Introduced, Referred to Assembly Health and Senior Services Committee

Subjects


New Jersey State Sources


Bill Comments

feedback